Island Pharmaceuticals Announces Key Board Retirements
Company Announcements

Island Pharmaceuticals Announces Key Board Retirements

Island Pharmaceuticals Ltd (AU:ILA) has released an update.

Island Pharmaceuticals Ltd has announced the retirement of key board members Dr. Paul MacLeman and Dr. Anna Lavelle following their 2024 Annual General Meeting. Both executives have played pivotal roles in the company’s strategic progress and clinical achievements. The company plans to appoint a new Chair soon, marking a significant transition as it continues its focus on antiviral drug development.

For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App